Medications to Fight HIV

Tags

Background

400. HIV Life Cycle

A diagram of the steps in the HIV life cycle.
[Revised: April 27, 2007]

401. Taking Current Antiretroviral Drugs (2 pages)

A chart showing currently approved antiretroviral drugs and standard dosages. There are notes on how to take and store each drug, and on the most common side effects.
[Revised: June 25, 2007]

402. Drug Names and Manufacturers

A chart showing the various names of HIV antiretroviral drugs, including their manufacturer and year of FDA approval.
[Revised: July 18, 2007]

403. What Is Antiretroviral Therapy (ART)?

An overview of antiretroviral drug therapy (ART) to treat HIV.
[Revised: June 25, 2007]

404. 2006 Antiretroviral Therapy Guidelines

A discussion of official US guidelines for treatment of HIV.
[Revised: October 10, 2006]

405. Adherence

Adherence means taking all your pills every day, on time. This fact sheet discusses why this is so important, and gives some advice on how to make it easier to do.
[Revised: July 18, 2007]

406. Treatment Interruptions

Many people with HIV would like to stop taking their medications, at least for a while. This might help some people, but it can have some serious risks.
[Revised: October 10, 2006]

407. Drug Interactions

Some drugs affect how quickly other drugs are removed from the body. This can cause an overdose or drug levels that are too low to be effective. Food and herbal products can also change drug levels.
[Revised: April 26, 2007]

408. Salvage Therapy

A description of "salvage therapy" for people with HIV who have used up most of their antiretroviral treatment options
[Revised: August 17, 2007]

Nukes: Nucleoside Analog Reverse Transcriptase Inhibitors

410. Nucleoside Analog Reverse Transcriptase Inhibitors in Development

A description of new reverse transcriptase inhibitors in human studies to fight HIV.
[Revised: August 15, 2007]

411. Zidovudine (Retrovir, AZT)

A description of the antiretroviral drug zidovudine (Retrovir®, AZT) including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 17, 2006]

412. Zalcitabine ((Hivid, ddC)

A description of the antiretroviral drug ddC (Hivid®) which was discontinued from manufacture and sale in February 2006.
[Revised: October 17, 2006]

413. Didanosine (Videx, ddI)

A description of the antiretroviral drug ddI (Videx®) including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 16, 2006]

414. Stavudine (Zerit, d4T)

A description of the antiretroviral drug d4T (Zerit®) including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 16, 2006]

415. Lamivudine (Epivir)

A description of the antiretroviral drug 3TC (Epivir®) including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 16, 2006]

416. Abacavir (Ziagen)

A description of the antiretroviral drug Abacavir (Ziagen®) including dosing, side effects, and a general discussion of who should take this drug.
[Revised: August 17, 2007]

417. Combivir (zidovudine + lamivudine)

A description of the antiretroviral medication Combivir®, a combination of zidovudine and lamivudine, including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 23, 2006]

418. Trizivir (zidovudine + lamivudine + abacavir)

A description of the antiretroviral medication Trizivir®, a combination of zidovudine, lamivudine, and abacavir, including dosing, side effects, and a general discussion of who should take this medication.
[Revised: July 23, 2007]

419. Tenofovir (Viread)

A description of the antiretroviral drug tenofovir (Viread®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: July 23, 2007]

420. Emtricitabine (Emtriva)

A description of the antiretroviral drug (ARV) emtricitabine (Emtriva®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: April 26, 2007]

421. Truvada (Tenofovir + Emtricitabine)

A description of the antiretroviral medication Truvada, a combination of tenofovir and emtricitabine, including dosing, side effects, and a general discussion of who should take this drug.
[Revised: April 26, 2007]

422. Epzicom (Kivexa, abacavir + lamivudine)

A description of the antiretroviral medication Epzicom, a combination of abacavir and 3TC, including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 16, 2006]

Non-Nukes or NNRTIs: Non-Nucleoside Reverse Transcriptase Inhibitors

430. Non-Nucleoside Reverse Transcriptase Inhibitors in Development

A description of non-nucleoside reverse transcriptase inhibitors in development against HIV.
[Revised: September 12, 2006]

431. Nevirapine (Viramune)

A description of the antiretroviral drug nevirapine (Viramune®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: August 16, 2007]

432. Efavirenz (Sustiva)

A description of the antiretroviral drug efavirenz (Sustiva®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: February 14, 2007]

433. Delavirdine (Rescriptor)

A description of the antiretroviral drug delavirdine (Rescriptor®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: May 13, 2007]

439. Atripla (efavirenz + emtricitabine + tenofovir)

A description of the three-in-one combination antiretroviral drug (ARV) Atripla®, including dosing, side effects, and a general discussion of who should take this drug.
[Revised: July 23, 2007]

Protease Inhibitors

440. Protease Inhibitors in Development

A description of protease inhibitors in development against HIV.
[Revised: December 18, 2006]

441. Indinavir (Crixivan)

A description of the antiretroviral drug indinavir (Crixivan®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: May 13, 2007]

442. Ritonavir (Norvir)

A description of the antiretroviral drug ritonavir (Norvir®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: May 13, 2007]

443. Saquinavir (Invirase)

A description of the antiretroviral drug indinavir (Invirase®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: September 10, 2006]

444. Nelfinavir (Viracept)

A description of the antiretroviral drug nelfinavir (Viracept®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: May 13, 2007]

445. Amprenavir (Agenerase)

A description of the antiretroviral drug Amprenavir (Agenerase®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: May 13, 2007]

446. Lopinavir + ritonavir (Kaletra)

A description of the antiretroviral drug Lopinavir (Kaletra®, Aluvia®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: November 9, 2006]

447. Atazanavir (Reyataz)

A description of the protease inhibitor drug atazanavir (reyataz) and its use to treat HIV.
[Revised: October 31, 2006]

448. Fosamprenavir (Telzir, Lexiva)

A description of the antiretroviral drug fosmprenavir (Lexiva®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: June 25, 2007]

449. Tipranavir (Aptivus)

A description of the protease inhibitor drug tipranavir (Aptivus)and its use to treat HIV.
[Revised: July 23, 2007]

450. Darunavir (Prezista)

A description of the protease inhibitor drug darunavir (Prezista) and its use to treat HIV.
[Revised: February 14, 2007]

Attachment and Fusion Inhibitors

460. Attachment and Fusion Inhibitors in Development

A description of fusion and attachment inhibitors in development against HIV, including CD4 blockers, CCR5 blockers, CXCR4 blockers and fusion inhibitors.
[Revised: May 7, 2007]

461. Enfuvirtide (Fuzeon)

A description of the antiretroviral drug Enfuvirtide (Fuzeon®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: February 14, 2007]

462. Maraviroc

Maraviroc (Selzentry in the US and Celsentri elsewhere) was formerly known as UK 427,857. It is a drug used for antiviral therapy.
[Revised: August 16, 2007]

Other Drugs to Fight HIV

470. Other Antiretroviral Drugs in Development

A description of new drugs in development to fight HIV, including integrase inhibitors, maturation inhibitors, zinc finger inhibitors, and others in human clinical trials.
[Revised: June 29, 2007]

479. Hydroxyurea (Hydrea)

A description of the drug hydroxyurea (Hydrea®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised: October 8, 2006]

Leave a Reply

You must be logged in to post a comment.

Copyright© 2016 | AIDS.org | All Rights Reserved. | Policies | Site Map | Contact Us | Prominent Web Design